Project Details
Wnt5a activates fibroblasts and induces fibrosis via the planar cell polarity pathway
Applicant
Professor Dr. Jörg Hans Wilhelm Distler, since 6/2017
Subject Area
Rheumatology
Term
from 2016 to 2021
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 283389830
Final Report Year
2021
Final Report Abstract
Wir konnten zeigen, dass WNT5A über eine ITGAV-abhängige Aktivierung von latentem TGFß eine Differenzierung von ruhenden Fibroblasten in Myofibroblasten induziert und alleine suffizient ist, um Fibrose zu induzieren. Diese profibrotischen Effekte werden über ROR2- und RYK-Rezeptoren sowie über ROCK- und JNK-Kinasen vermittelt. Die Hemmung dieser Signalkaskade, durch Knockout von WNT5A, durch ROCK- oder JNK-Inhibitoren, oder durch Überexpression eines ROR2-Fc-Decoy Rezeptors hemmen Fibrose in verschiedenen Mausmodellen.
Publications
- Activation of Signal Transducer and Activator of Transcription 3 (STAT3) integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nat Commun. 2017 Oct 24;8(1):1130
Chakraborty D, Šumová B, Mallano T, Chen CW, Distler A, Bergmann C, Ludolph I, Horch RE, Gelse K, Ramming A, Distler O, Schett G, Šenolt L, Distler JH
(See online at https://doi.org/10.1038/s41467-017-01236-6) - JAK1-dependent transphosphorylation of JAK2 limits the anti-fibrotic effects of selective JAK2 inhibitors upon long-term treatment. Ann Rheum Dis. 2017 Aug;76(8):1467-1475
Zhang Y, Liang R, Chen C-W, Mallano T, Dees C, Distler A, Reich A, Bergmann C, Ramming A, Gelse K, Milenz D, Distler O,Schett G, Distler JH
(See online at https://doi.org/10.1136/annrheumdis-2016-210911) - Nintedanib macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis. Ann Rheum Dis., Ann Rheum Dis. 2017 Aug 16
Huang J, Maier C, Zhang Y, Soare A, Dees C, Beyer C, Harre U, Chen C-W, Distler O, Schett G, Wollin L, Distler JH
(See online at https://doi.org/10.1136/annrheumdis-2016-210823) - The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis. Ann Rheum Dis. 2017 Oct 25
Bergmann C, Brandt A, Merlevede B, Hallenberger L, Dees C, Wohlfahrt T, Pötter S, Zhang Y, Chen CW, Mallano T, Liang R, Kagwiria R, Kreuter A, Pantelaki I, Bozec A, Abraham D, Rieker R, Ramming A, Distler O, Schett G, Distler JHW
(See online at https://doi.org/10.1136/annrheumdis-2017-211501) - Protein kinases G are essential downstream mediators of the antifibrotic effects of sGC stimulators. Ann Rheum Dis. 2018 Jan 8
Matei AE, Beyer C, Györfi AH, Soare A, Chen CW, Dees C, Bergmann C, Ramming A, Friebe A, Hofmann F, Distler O, Schett G, Distler JHW
(See online at https://doi.org/10.1136/annrheumdis-2017-212489) - PU.1 controls fibroblast polarization and tissue fibrosis. Nature. 2019 Jan 30
Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici A, Weber S, Matei AE, Chen CW, Maier C, Karouzakis E, Kiener HP, Pachera E, Dees C, Beyer C, Daniel C, Gelse K, Kremer AE, Naschberger E, Stürzl M, Butter F, Sticherling M, Finotto S, Kreuter A, Kaplan MH, Jüngel A, Gay S, Nutt SL, Boykin DW, Poon GMK, Distler O, Schett G, Distler JHW, Ramming A
(See online at https://doi.org/10.1038/s41586-019-0896-x) - TGFβ-induced epigenetic deregulation of SOCS3 facilitates STAT3-signaling to promote fibrosis. J Clin Invest. 2020 May 1;130(5):2347-2363
Dees C, Pötter S, Zhang Y, Bergmann C, Zhou X, Luber M, Wohlfahrt T, Karouzakis E, Ramming A, Gelse K, Yoshimura A, Jaenisch R, Distler O, Schett G, Distler JHW
(See online at https://doi.org/10.1172/JCI122462)